Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk

Detalles Bibliográficos
Autores principales: Behr, Paulo Eduardo Ballvé, Moriguchi, Emilio Hideyuki, Castro, Iran, Bodanese, Luiz Carlos, Dutra, Oscar Pereira, Leães, Paulo Ernesto, Pimentel Filho, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia - SBC 2018
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078356/
https://www.ncbi.nlm.nih.gov/pubmed/30110052
http://dx.doi.org/10.5935/abc.20180133
_version_ 1783345078715023360
author Behr, Paulo Eduardo Ballvé
Moriguchi, Emilio Hideyuki
Castro, Iran
Bodanese, Luiz Carlos
Dutra, Oscar Pereira
Leães, Paulo Ernesto
Pimentel Filho, Pedro
author_facet Behr, Paulo Eduardo Ballvé
Moriguchi, Emilio Hideyuki
Castro, Iran
Bodanese, Luiz Carlos
Dutra, Oscar Pereira
Leães, Paulo Ernesto
Pimentel Filho, Pedro
author_sort Behr, Paulo Eduardo Ballvé
collection PubMed
description
format Online
Article
Text
id pubmed-6078356
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Sociedade Brasileira de Cardiologia - SBC
record_format MEDLINE/PubMed
spelling pubmed-60783562018-08-16 Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk Behr, Paulo Eduardo Ballvé Moriguchi, Emilio Hideyuki Castro, Iran Bodanese, Luiz Carlos Dutra, Oscar Pereira Leães, Paulo Ernesto Pimentel Filho, Pedro Arq Bras Cardiol Viewpoint Sociedade Brasileira de Cardiologia - SBC 2018-07 /pmc/articles/PMC6078356/ /pubmed/30110052 http://dx.doi.org/10.5935/abc.20180133 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Viewpoint
Behr, Paulo Eduardo Ballvé
Moriguchi, Emilio Hideyuki
Castro, Iran
Bodanese, Luiz Carlos
Dutra, Oscar Pereira
Leães, Paulo Ernesto
Pimentel Filho, Pedro
Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk
title Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk
title_full Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk
title_fullStr Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk
title_full_unstemmed Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk
title_short Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk
title_sort indications of pcsk9 inhibitors for patients at high and very high cardiovascular risk
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078356/
https://www.ncbi.nlm.nih.gov/pubmed/30110052
http://dx.doi.org/10.5935/abc.20180133
work_keys_str_mv AT behrpauloeduardoballve indicationsofpcsk9inhibitorsforpatientsathighandveryhighcardiovascularrisk
AT moriguchiemiliohideyuki indicationsofpcsk9inhibitorsforpatientsathighandveryhighcardiovascularrisk
AT castroiran indicationsofpcsk9inhibitorsforpatientsathighandveryhighcardiovascularrisk
AT bodaneseluizcarlos indicationsofpcsk9inhibitorsforpatientsathighandveryhighcardiovascularrisk
AT dutraoscarpereira indicationsofpcsk9inhibitorsforpatientsathighandveryhighcardiovascularrisk
AT leaespauloernesto indicationsofpcsk9inhibitorsforpatientsathighandveryhighcardiovascularrisk
AT pimentelfilhopedro indicationsofpcsk9inhibitorsforpatientsathighandveryhighcardiovascularrisk

Ejemplares similares